Your browser doesn't support javascript.
loading
Human Serum With High Neutralizing Antibody Titers Against Both Zika and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue Virus Infection.
Valiant, William G; Lalani, Tahaniyat; Yun, Heather C; Kunz, Anjali; Burgess, Timothy H; Mattapallil, Joseph J.
Afiliación
  • Valiant WG; F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, Maryland.
  • Lalani T; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Rockville, Maryland.
  • Yun HC; Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland.
  • Kunz A; Division of Infectious Diseases, Naval Medical Center, Portsmouth, Virginia.
  • Burgess TH; San Antonio Military Medical Center, San Antonio, Texas.
  • Mattapallil JJ; Madigan Army Medical Center, Tacoma, Washington.
Open Forum Infect Dis ; 5(7): ofy151, 2018 Jul.
Article en En | MEDLINE | ID: mdl-30019003
ABSTRACT
Zika virus infection in a dengue virus-naïve subject was associated with the induction of high levels of cross-reactive binding antibodies. These responses were, however, largely non-neutralizing and displayed a capacity to enhance dengue infection in vitro at significantly low dilution (110). In contrast, a subject who had high levels of neutralizing antibodies against both dengue and Zika viruses enhanced infection at a dilution of 110 000. These results suggest that high levels of dengue cross-neutralizing antibodies could potentially prevent the enhancement of dengue infection in Zika virus-convalescent individuals.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2018 Tipo del documento: Article